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Cell kinetics parameters have been analysed in colonic mucosa at different distances from a tumour in patients with colon carcinoma.
Total cell number (TCN), 3H thymidine labelling index (TLI), mitotic index (MI), Goblet cell index (GCI) and the distribution of labelled
cells along the crypt column (cell position frequency plot) were determined in well-aligned crypts. Total cell number, GCI and the labelled
cell position frequency plots were similar in different samples from the same individual. A negative linear correlation between TCN and
TLI was observed. The analysis of the cell position plots showed two patterns 1) with a high concentration in the bottom fifth of the crypt
and 2) with frequent labelled cells at high positions. Whereas a negative correlation between overall TLI and the percent contribution to
the TLI of the lowermost fifth was seen, the correlation was positive for the next 3 fifths and labelling was absent in the last part of the
crypt.
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ORIGINAL ARTICLE
Under steady state conditions in healthy tissue the levels of
proliferation are controlled by homeostatic mechanisms
which can be influenced by physical, chemical and biologi-
cal factors to induce new proliferative situations that can
be transitory or more permanent if the system is chroni-
cally assaulted. In the latter case, a new steady state may
be achieved which is characterised by increased mitotic
activity and this may be of relevance in carcinogenesis
(1–3). Alterations in proliferative and structural aspects of
the proliferative compartment are believed to precede can-
cer development (4). Experimental evidence in rats and
mice support this sequence of hyperproliferation, tissue
distortion and carcinogenesis (5–8). With this is mind,
surgical specimens of human large intestine have been
studied on the assumption that although cancer is very
specifically located there is the possibility that the whole
colonic mucosa may show some pre-neoplastic changes
(e.g. increased proliferation) since it may have been ex-
posed to the same chronic stimuli and will have the same
genetic constitution. Over the last few years, in vitro
(bromodeoxyuridine or tritiated thymidine, 3HTdR) and in
vivo (bromodeoxyuridine) techniques have been developed
for studying the proliferative activity in tissues taken at
surgery (9–15). Because of the potential ethical difficulties
associated with bromodeoxyuridine in vivo we have a
preference for 3HTdR incubation ex vivo.
The aim of the present study was to evaluate the prolif-
erative activity in the normal mucosa of patients affected
by colon cancer. Samples were collected at various dis-
tances from the tumour and the 3HTdR labelling index
(TLI), the mitotic index (MI) and the Goblet cell index
(GCI) were determined. By selecting well-oriented, longitu-
dinally cut crypts the spatial distribution of S-phase cells
along the crypt axis can be determined. Analyses were
performed on multiple sample from each patient.
MATERIAL AND METHODS
Tissue samples
Samples were obtained at surgery from 13 subjects (9
females, 4 males) with a median age of 73 years (range
56–85 years). The patients all suffered from colonic car-
cinomas (2 caecal, 1 in the ascending colon, 3 in the
transverse colon, 1 in the descending colon and 6 in the
sigmoid region of the colon). None of the patients suffered
from any other gastrointestinal illness. Immediately after
surgery, samples of large intestine mucosa were taken 5 cm
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Table 1
An example of one case of the counting procedure and the 6ariability in total cell number (TCN), thymidine labelling index (TLI), mitotic
index (MI) and Goblet cell index (GCI) as mean9S.E.M.) in the periphery (P), centre (C) and total (T) of the sample taken at 20 cm
(A) and 5 cm before (B) and 5 cm after the tumour (C). The total number of sections and crypts analysed are also shown
GCI (M9S.E.)Area No. of sections No. of crypts TCN (M9S.E.) TLI (M9S.E.) MI (M9S.E.)
0.0390.03A T 45 229 58.392.4 7.690.74.690.5
6.391.20P 4.790.613 90 60.395.5
4.590.8 0.0490.04C 8.590.532 139 57.092.7
0.00990.006 9.291.5B 5.090.7T 51 323 57.891.3
0.0190.01P 23 102 56.792.3 5.291.4 7.392.3
0.00790.008C 28 211 58.791.6 4.890.9 10.792.0
0.0690.02 8.890.6C 5.790.6T 50 341 56.891.4
5.790.9 0.0990.01P 8.990.529 244 56.892.5
0.0490.003C 21 97 58.490.8 9.491.94.690.5
above and below the tumour respectively. Some samples
were also taken at 20 cm above (n10) or below (n3)
the tumour.
Tissue treatment
Preliminary studies showed that there were some
difficulties in 3HTdR uptake when intact fragments of
large intestine were incubated in vitro possibly due to
penetration difficulties resulting in only some of the crypts
at the periphery of the tissue becoming labelled (11, 16).
To overcome this we initially used various concentrations
of mucolytic molecules, such as ursodeoxycolic acid and
sodium dodecylsulphate for different lengths of time, but
such treatments induced morphological alterations in the
epithelial cells which may affect permeability and length of
the cell cycle. A subsequent approach involved the gentle
removal by application of filter paper of the mucus from 2
cm2 pieces of the mucosa which were then placed on velcro
to maintain the orientation of the tissue during sectioning.
Each sample was then incubated for 90 min in 9 ml of
McCoy’s 5A medium (84%), with foetal calf serum (15%),
tritiated thymidine (1%, specific activity 740 GBq:mmol,
Amersham UK) at 37°C with continuous stirring and a gas
environment of 5% CO2 with air. Before incubation the
mucosa was punctured repeatedly in an attempt to in-
crease the probability of 3HTdR uptake. After incubation,
the tissue was washed 3 times in cold saline and fixed for
50 min in Carnoy’s fixative. Following this, the mucosa
was cut into 15–20 fragments of about 0.3–0.4 cm in
width that were held separately, recording their position in
relation to the original piece of tissue.
After embedding in polystyrene (17) sections were cut at
3 mm and autoradiographs were prepared using Ilford K5
emulsion. The sections were stained with haematoxylin-
erythrosin or periodic acid Schiff’s (PAS)-haematoxylin.
Scoring techniques
Only crypts that were well aligned longitudinally and
which contained at least 1 labelled cell were selected for
scoring which was taken as evidence that the 3HTdR had
reached the crypt by diffusion. Almost all the crypts in the
samples had at least one labelled cell. The total number of
epithelial cells, labelled cells, mitotic cells and Goblet cells
were counted along the side of the crypt section starting at
the crypt base. From these numbers, the thymidine la-
belling index (TLI), the mitotic index (MI) and the Goblet
cell index (GCI) were calculated. Furthermore, the posi-
tion of the labelled and mitotic cells was recorded along
the crypt axis starting with the first cell at the base. Except
for one case a minimum of 50 crypt sides were scored in
this way; usually many more than 50 were scored. Every
4th section was scored to avoid the possibility of recount-
ing the same crypt. At least 5 fragments for each mucosal
sample, at each location, were evaluated for sample-to-
sample variation. For the mitotic counting, cells in late
prophase, metaphase and anaphase were recorded and for
the Goblet cell counting, PAS positive cells with an evident
nucleus were recorded. The 13 patients provided 33 sam-
ples in total but only in 12 patients could all the scoring be
performed resulting in 31 samples for presentation. Mean
values9S.E. were determined and the Wilcoxon rank test
was used to test for statistical significance.
The cell positional localisation of labelled cells along the
side of a crypt was registered and a frequency plot for a
normalised crypt was calculated using a computer pro-
gramme (18–24).
The data for the frequency plots have been subdivided
into 5 crypt compartments each comprising 20% of the
crypt length and the relative number of labelled cells in
each compartment has been analysed.
RESULTS
There were no morphological mucosal abnormalities in
any of the samples. The 3HTdR labelling was uniform in
distribution over the peripheral and central tissue speci-
mens (an example of one case is shown in Table 1). This
test was repeated in 6 patients and only occasionally were
any differences observed. As a consequence of this, we felt
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Table 2
Variation in measurements between patients in TCN, TLI, MI and GCI (as mean9S.E.M.). In the epithelium at different distances before
(A), (B) and after (C) the tumour (see Table 1 for details). The results are for 3 patients with cancer in the sigmoid region
GCI (M9S.E.)Area No. of sections No. of crypts TCN (M9S.E.) TLI (M9S.E.) MI (M9S.E.)
0.1390.05F 58 yrs A 28 208 62.491.7 7.290.75.291.5
8.090.30.1690.09B 5.190.524 221 62.892.3
9.290.6C 24 245 52.690.4 6.091.4 0.0490.007
0.0690.03M 82 yrs A 45 158 84.692.1 11.090.72.290.1
16.990.60.0690.04B 3.190.357 209 72.392.4
3.090.8 0.00190.001 12.992.0C 34 104 79.093.6
0.3090.05F 62 yrs A 28 175 52.091.2 1.590.14.590.2
5.090.30.1890.05B 4.691.329 179 56.791.8
5.090.5 0.0590.03C 4.090.725 193 62.092.5
that counting could be performed in any of the samples
chosen. Although this analysis showed that the labelling
parameters were the same in each fragment taken from the
same sample, or from fragments taken at different posi-
tions from the same patient, there were some differences
observed when mitotic activity was considered. This is
probably due to the fact that mitosis is a short phase in the
cell cycle and as a consequence the mitotic index is very
low. However, it may also be due to the fact that some
mitoses are lost in the interval between resection and
fixation. For an example of the sort of variability observed
of 3 samples from 3 different patients, see Table 2. Table
3 summarises the results from all 13 patients. The mean
value of the number of cells per crypt column (cells along
one side of the crypt) was 63.6 (median is 62.4) with a
range of 42.8–86.9. No significant differences were ob-
served in any of the cases with distance from the neoplasia.
For the 13 subjects the mean labelling index (TLI) was
5.3% (median 5.0%) with a range of 2.1–10.7%. No spe-
cific relationships were seen within this small sample be-
tween labelling index and age, sex and site of tumour.
There is a statistically significant correlation between TLI
and number of cells per crypt column (TCN) as shown by
Fig. 1. The TLI is generally greater in those cases with a
lower number of epithelial cells per crypt column. In
contrast, the number of S-phase cells per crypt (as opposed
to TLI) is quite homogeneous with a median value of 3.0
and a mean9S.E.M. of 3.290.2 with a range from
2.0–4.2. The mitotic index varies widely with a range from
0.001–1.24% with a mean value of 0.21% (median 0.13%).
Amongst all the parameters analysed, this is the only one
which, due to the low frequency of mitoses, varies sharply
between different crypts in the same section and different
mucosal specimens from the same subject.
The percentage of Goblet cells (GCI) in each crypt
varies between 1.3 and 16.9% with a median value of 5.0
and a mean of 5.7%. The frequency of Goblet cells in the
right colon tends to be lower than in the other regions of
the large intestine. In Table 4 the TLI and GCI mean
values are presented for three regions of the colon consid-
ering the 5 and 20 cm samples together. The GCI values
show a significant (pB0.05) increase in the descending
colon compared with the ascending region.
The distribution of S-phase cells (labelled cells) along
the crypt length is low at the bottom, increases and reaches
a maximum generally within the first 20% of the crypt. It
decreases higher up the crypt. In most of the crypts, the
proliferative compartment is thus confined to the lower
half and only exceptionally are labelled cells observed in
the uppermost 20% of the crypt. The cell position fre-
quency plot for labelled cells tends to be characteristic for
each patient. Typical frequency plots are shown in Fig. 2;
Fig. 2a shows the most frequently observed distribution.
Fig. 1. Relationship between total cell number (TCN) along one
side of the crypt and TLI in 33 samples of colonic epithelium
(r0.635, p0.00007) from 13 patients.
Table 3
Mean9S.E.M., median and ranges TCN (total cell number), MI
(mitotic index) and GCI (goblet cell index) in all 33 samples from
the 13 cases
MI%TLI% GCI%TCN
Mean9S.E. 63.692.1 5.390.4 0.2190.04 5.790.7
Median 5.00.135.062.4
Range 41.8–86.9 2.1–10.7 0.001–1.24 1.3–16.9
A
ct
a 
O
nc
ol
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
 S
tu
di
 d
i F
ire
nz
e 
on
 0
7/
19
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
A. Becciolini et al. Acta Oncologica 37 (1998)68
Table 4
Mean9S.E.M. and ranges of TLI and GCI in 26 samples of
colonic mucosa from 13 cases studied separated into three regions.
* statistically significant difference (pB0.05)
TransverseAscending Descending
TLI%
5.3990.71Mean9S.E. 4.5690.506.6390.79
3.05–7.353.74–10.22 2.22–10.67Range
GCI%
5.8090.97Mean9S.E. 2.8490.71* 7.1191.55*
2.60–14.921.27–7.60 1.47–10.98Range
810Number of 8
samples
gate possible global changes in proliferation that might
predispose to cancer or be part of the processes leading to
neoplastic change.
With our technique we see good thymidine diffusion
uptake and labelling and did not encounter the problems
reported elsewhere (11, 16). Using selected crypts that were
Fig. 2. Individually labelled cell position distributions for three
patients showing different types of mucosal proliferation; A) the
more frequently observed type of distribution; B) and C) show
types of expansion of the proliferative compartment.
When the average TLI is high the area under the curve
is also high with a tendency to proliferative activity at high
cell positions (Fig. 2b). In one subject, a slightly different
pattern was noted with a shift in the TLI towards the
middle and upper regions of the crypt (Fig. 2c). Generally,
the greatest spread in the proliferative compartment was in
those subjects with the lowest total number of epithelial
cells per crypt column. The present limited data do not
show any specific trend in the S-phase cell distribution in
different sites of the large bowel, nor any particular trend
related to the distance from the colonic tumour.
When the TLI values for each of the 31 samples from
the 12 patients are ranked according to increasing TLI
values for each of the different fifths of the crypt the
lowest fifth generally contains between 50 and 96% of the
labelling (see Table 5). The second and third fifths of the
crypt usually contain between about 5–25% and 1–5%
respectively. In the upper 2 fifths labelled cells do not
usually occur. This is the general pattern seen. A second
pattern shows less of a difference between the lowest and
the immediately adjacent fifth with the percent contribu-
tion to the TLI ranging between 7 and 30% in the third
fifth with a few labelled cells in the fourth and fifth regions
(examples are marked in Table 5).
Linear regression analysis obtained from the 33 samples,
showed a negative correlation between the TLI and the
percent contribution in the lowest 20% of the crypt (r
0.74) with pB0.000001) (Fig. 3). In contrast, a positive
correlation was observed between TLI values and the
contribution to the TLI in the second, third and fourth
segments (r0.668; 0.678 and 0.368 respectively with p-
values B0.0001; 0.0001 and 0.04 respectively). No rela-
tionship was found between the overall TLI and the
percent contribution to the TLI of the uppermost fifth of
the crypt.
DISCUSSION
The present study of the total labelling index and labelled
cell distribution in the crypt in ‘healthy’ normal epithelium
of colonic cancer patients has been undertaken to investi-
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Table 5
TLI 6alues for the 31 samples from 12 patients ranked in
order. The relati6e proportion (%) of labelled cells seen in
each fifth of the crypts is shown. Samples with possible
different patterns are marked
TLI%Patient % of labelled cells in each fifth
3rd 5th4th1st 2nd
2.2 2.51 2.13 88.7 06.6
002 1.72.22 88.1 10.2
03 2.75 96.3 2.8 0.9 0
02 2.97 72.2 22.4 5.4 0
0 02 3.33.14 67.0 29.7
0.8 03 3.21 90.3 08.9
004 2.23.26 79.4 18.3
05 3.33 92.2 6.2 1.6 0
1.06 3.46 91.1 6.8 0.7 0.5
1.8 2.46 1.63.60 88.9 5.3
1.0 0 04 4.18 89.1 9.9
0.926.27 48.74.49** 13.6 10.7
2.08 4.57 58.3 32.3 7.2 0.2
2.17 4.60 61.8 25.9 10.2 0
2.0 09 16.34.65* 54.9 26.8
0.810 4.79 68.5 22.4 08.3
02.48 13.34.95* 50.3 34.0
2.17 5.02 52.1 42.5 3.2 0
0.511 5.12 79.7 16.9 2.9 0
0.2 011 3.05.24 71.0 25.9
10.6 1.4 01 5.36* 55.2 32.6
011.312 26.05.49** 24.7 38.0
0.73 5.68 49.5 42.5 7.3 0
5.13 5.95* 50.0 31.1 13.9 0
0.9 011 15.15.99* 55.7 28.4
7.2 0.33 06.47 59.6 32.8
005 11.66.63* 35.7 52.6
1.910 6.77* 56.4 28.3 13.5 0
12.312 7.35** 25.9 29.6 30.2 2.0
2.1 01 12.37.59 54.1 31.3
17.7 2.86 0.410.67* 42.9 36.2
* High LI% in 2nd fifth of the crypt.
** High LI% in 3rd fifth of crypt.
be explained by the different methods of labelling. The in
vivo administration of BrdUrd gives a physiological
Fig. 3. Linear regression analysis of the relative percent contribu-
tion (relative TLI) to the total thymidine labelling index (TLI)
observed in the various compartments (fifths) of the crypt: A)
lowest fifth (0–20%) r0.740, p106; B) the second fifth
(21–40%), r0.688 p0.00006; C) the third fifth (41–60%),
r0.678 p0.00004.
longitudinally aligned, we have been able to measure pro-
liferation in relation to cell position in the crypt. Because
relatively few subjects were analysed, no conclusions could
be drawn concerning the effects on proliferation of age,
sex, site or stage of colonic cancer, nor between position in
the gut and distance from the tumour. However, the
present data would seem to suggest that none of these
factors have a large effect. The frequency plots for labelled
cells along a side of the crypt reported here after incuba-
tion with 3HTdR are similar in general shape to those
obtained from 77 English patients injected with bromo-
deoxyuridine (BrdUrd) (14, 15) (see Fig. 4) which confirms
the validity of the in vitro method. The general pattern is
similar but in the earlier study more labelled cells were
seen in the second fifth of the crypts. The differences may
A
ct
a 
O
nc
ol
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
 S
tu
di
 d
i F
ire
nz
e 
on
 0
7/
19
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
A. Becciolini et al. Acta Oncologica 37 (1998)70
Fig. 4. Labelled cell distribution in 77 samples of human colonic
mucosa after in vivo administration of BrUdR presented else-
where (14, 15) compared with the overall average labelled cell
distribution with its standard error limits for the 33 samples of
human colonic epithelium from 13 colonic carcinoma patients
analysed here.
labelled cells at higher positions without a corresponding
increase in the overall TLI.
The frequency distributions of labelled cells were not
affected by the site of the tumour or the proximity of the
specimen to the tumour. Generally, high TLI values corre-
sponded to lower Goblet cell frequencies and lower Goblet
cell indices corresponded to a greater spread of the prolif-
erative compartment which confirms somewhat, the hypoth-
esis that the number of Goblet cells and hence differentiation
is related inversely to the level of proliferation.
Earlier studies in animals exposed to abdominal sublethal
doses of ionising radiation showed that during the repopu-
lation phase in the small intestine, there was a significant
increase in the number of S-phase and mitotic cells (18–20,
25–29). These changes are co-ordinated with an expansion
of the proliferative compartment and labelled cells can be
found in the upper parts of the crypts where, under normal
conditions, the cells would be differentiated and character-
ised by brush border enzyme synthesis. At these times,
Goblet cells are infrequent. These changes are transitory
and disappear some days after irradiation, later the higher
the dose of radiation. After the repopulation phase, when
the principal columnar cell line prevails, the proliferative
compartment returns to normal dimensions with the normal
production of markers of differentiation such as Goblet
cells and brush border enzymes (20, 21, 24, 30–33).
The results of the present study, although based on
relatively few patients and in a restricted area of the large
intestine, show no sign of the general changes in prolifera-
tive activity associated with cancer which have been consid-
ered by some as an indicator of high risk for neoplasia (6).
In the present series, the variations seen in the total cell
number and the TLI are linked more closely with variability
between individual patients. Only occasional modifications
were present, and these seemed to be unrelated to site or
position in relation to the tumour.
In summary, the present study has shown or confirmed
some interesting aspects of colonic mucosal biology.
Firstly, there is an increasing trend in Goblet cell number
from the ascending to the sigmoid colon. Secondly, the
total cell number, i.e. crypt size in the area examined,
seems to be a characteristic for an individual patient.
Thirdly, the number of S-phase (or labelled) cells is re-
markably constant in spite of variations in the total cell
number per crypt, and lastly, a spread in the proliferative
compartment towards the surface of the mucosa corre-
sponds generally with an increase in TLI. This is not a
consistent finding since sometimes tumours can be found
in patients with a colonic mucosa which characteristically
has a low proliferative activity. This observation is in
contrast with some previous reports where there was an
association between the presence of tumour and an evident
general increase in proliferative activity (34). However,
other recent studies have suggested that the proliferative
activity in colonic mucosa adjacent to tumours is generally
availability of label rather than a reliance on diffusion.
There is also the possibility that some differences may be
attributable to the differences in life-style between the two
groups of patients (Italian-v-English).
The fact that the total number of cells per crypts column
in different samples from the same subject did not vary
suggests that the size of the crypt may be typical of an
individual and likely to be largely constant throughout the
area of the large bowel examined. The mitotic index is not
a particularly useful cell proliferation parameter because of
the small numbers of cells in mitosis. The total number of
labelled cells does not vary much but there is some vari-
ability in the labelling index because of differences in cell
numbers per crypt. A negative linear correlation between
the TLI and the total cell number was observed.
From the frequency cell plots for labelled cells it is
evident that the majority of labelled cells are within the
lowest fifth of the crypt with a steep decline in the number
of labelled cells in the next fifth and an absence of label in
the upper fifth. These frequency plots seem to be typical
for each individual and even to be similar in all the
specimens from different sites from a particular individual.
Only occasionally did one of the specimens in a series from
an individual differ from the others. If this was the case,
then the differences were either of 1 or 2 types.
Firstly, a high number of labelled cells more or less
equally distributed between the 2 lowermost fifths with a
general decline thereafter. The results show that the in-
creased proliferative activity in some crypts does not corre-
spond to an increased labelled cell frequency in the lower
regions of the crypt, but in contrast, an upward shift of the
zone of proliferation as was observed elsewhere for the
proliferative changes in polyposis coli (14). Secondly, in
just a few cases there was an increase in the distribution of
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depressed when compared with sites distant from the
tumour (14, 15).
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